IP Library Patent Application 11838024
Patent Application
App. No. 11/838,024

Methods for Rapid, Single-Step Strand Displacement Amplification of Nucleic Acids

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/838,024
Filed
Aug 13, 2007
Examiner
KIM, YOUNG J
Art Unit
1637
USPC
435/6
Abstract

A single-step, isothermal strand displacement amplification method that is conducted without the requirement for heat denaturation of the target nucleic acid. The method is particularly useful for analysis of clinical samples due to the decreased risk of potential contamination of the patient sample.

Claims (22)

1 . A method for isothermal strand displacement amplification of nucleic acids, the method comprising the step of:

combining, in a single reaction vessel, a mixture of:

i. double-stranded target nucleic acid;

ii. a nicking enzyme capable of nicking the double-stranded target nucleic acid; and

iii. a DNA polymerase lacking 5 ′- 3 ′ exonuclease activity; under conditions sufficient to allow amplification of the target nucleic acid.

2 . The method of claim 1 , wherein the nicking enzyme is N.BbvClB and the DNA polymerase is Bst DNA polymerase.

3 . The method of claim 2 , wherein the N.BbvClB and Bst DNA polymerase are present in an approximately equimolar amount.

4 . The method of claim 3 , wherein the N.BbvClB and Bst DNA polymerase are present at a concentration of about 4 U each.

5 . The method of claim 1 , wherein the conditions sufficient to allow amplification of the target nucleic acid include incubation at a temperature ranging from about 45° C. to about 55° C.

6 . The method of claim 4 , wherein the conditions sufficient to allow amplification of the target nucleic acid include incubation at about 45° C.

7 . The method of claim 1 , wherein the target nucleic acid is genomic DNA.

8 . The method of claim 7 , wherein the genomic DNA is obtained from a patient in need of a clinical diagnosis.

9 . A method for isothermally amplifying a target nucleic acid, the method comprising the steps of:

a. providing a target double-stranded nucleic acid containing the target nucleic acid sequence and a sequence capable of being recognized by a nicking enzyme;

b. providing a nicking enzyme;

c. nicking the target double-stranded nucleic acid with the nicking enzyme to provide at least two new 3 ′ termini in the nucleic acid;

d. providing a DNA polymerase lacking 3 ′- 5 ′ exonuclease activity;

e. extending one or more of the at least two new 3 ′ termini with the DNA polymerase thereby producing a newly synthesized strand; and

f. repeating the nicking and extending steps such that the target nucleic acid sequence is amplified

under conditions sufficient to allow amplification without addition of external deoxynucleoside triphosphate moieties.

10 . The method of claim 9 , wherein the nicking enzyme is N.BbvClB and the DNA polymerase is Bst DNA polymerase.

11 . THe method of claim 9 , wherein the conditions sufficient to allow amplification of the target nucleic acid include incubation at a temperature ranging from about 45° C. to about 55° C.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2009
From: NANOGEN, INC.; EPOCH BIOSCIENCES, INC.; NANOTRONICS, INC.
To: ELITECH HOLDING B.V.
Reel/Frame 023004/0585 →
GRANT OF SECURITY INTEREST Recorded Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2007
From: YAO, ZUXU; LIDGARD, GRAHAM P.
To: NANOGEN, INC.
Reel/Frame 020204/0622 →